Funding for this research was provided by:
NHS England Project Award via the London Cancer Screening Board
Received: 28 June 2022
Accepted: 11 July 2022
First Online: 19 July 2022
: The study has been granted a favourable ethical opinion from London- Surrey Research Ethics Committee (reference 22/LO/0325). Consent to participate in the survey will be written via an online form hosted on the survey website. The need for explicit consent to participate in the trial was waived by the above Institutional Review Board as receipt of messages from screening hubs forms a part of usual care practice, and in the current study would potentially impact screening behaviours.
: Not applicable in this study. Findings from the trial will be disseminated in academic peer-reviewed publications, as well as a report to screening services in London to guide their policies.
: Professor Ara Darzi is Chair of the Health Security initiative at Flagship Pioneering UK Ltd. Flagship Pioneering had no role in the development, conduct or analysis of the current study. The other authors declare that they have no competing interests.